Kusha Davar

9PUBLICATIONS
23CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Ethical use of new technologyMedical bacteriologyCurriculum and pedagogy theory and development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 17, 2026
Health Economic Analysis of the AMBITION Protocol for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis in the United States.

|Aug 11, 2026
Cefadroxil as Oral Transitional Therapy for Gram-Positive Bacteremia With or Without Non-Vertebral Osteomyelitis: A Multicenter Retrospective Cohort Study.

|Jun 28, 2025
Practicing With Intent: How to Teach an Old Dogma New Tricks.

Matthew C Phillips, Kusha Davar, Sarah Freling

|Jul 28, 2023
Burying Hatchets into Endemic Diagnoses: Disseminated Blastomycosis from a Potentially Novel Occupational Exposure.

Kusha Davar, Arthur Jeng, Suzanne Donovan

|May 06, 2023
The PEST (Pathology, Epidemiology, Severity, Treatment) approach to optimizing antimicrobial therapy.

Kusha Davar, Tara Vijayan

|Mar 07, 2023
Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study.

Sarah Freling, Noah Wald-Dickler, Josh Banerjee

Pageof 2

Frequent Collaborators

3 joint publications

Noah Wald-Dickler

3 joint publications

Sarah R Freling

2 joint publications

Todd C Lee

2 joint publications

Josh Banerjee